Calcium and heart failure: How did we get here and where are we going?

Natthaphat Siri‐angkul, Behzad Dadfar, Riya Jaleel, Jazna Naushad, Jaseela Parambathazhath, Angelia A. Doye, Lai Hua Xie, Judith K. Gwathmey

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations

Abstract

The occurrence and prevalence of heart failure remain high in the United States as well as globally. One person dies every 30 seconds from heart disease. Recognizing the importance of heart failure, clinicians and scientists have sought better therapeutic strategies and even cures for end-stage heart failure. This exploration has resulted in many failed clinical trials testing novel classes of pharmaceutical drugs and even gene therapy. As a result, along the way, there have been paradigm shifts toward and away from differing therapeutic approaches. The continued prevalence of death from heart failure, however, clearly demonstrates that the heart is not simply a pump and instead forces us to consider the complexity of simplicity in the pathophysiology of heart failure and reinforces the need to discover new therapeutic approaches.

Original languageEnglish (US)
Article number7392
JournalInternational journal of molecular sciences
Volume22
Issue number14
DOIs
StatePublished - Jul 2 2021

All Science Journal Classification (ASJC) codes

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Keywords

  • Beta blocker
  • Calcium tran-sient
  • Excitation–contraction coupling
  • Heart failure
  • Hypoxia
  • Inotrope
  • Myocardial contractility
  • Myofilament
  • Sarcoplasmic reticulum
  • Sarcoplasmic reticulum Ca ATPase

Fingerprint

Dive into the research topics of 'Calcium and heart failure: How did we get here and where are we going?'. Together they form a unique fingerprint.

Cite this